The first study found an association of ATP13A4 with high-grade serous ovarian carcinoma [45], while the second study linked ATP13A4 to lung adenocarcinoma through anaplastic lymphoma kinase (ALK) rearrangements [46]. Here, ATP13A4 is linked to lung adenocarcinoma.